Tango Therapeutics, Inc. · NASDAQ:TNGX

Dapice Joshua J. reported a 6.60% stake in Tango Therapeutics, Inc. (Schedule 13G)

Event Jun 6, 2025 · Filed Jun 13, 2025

Dapice Joshua J. reported a 6.60% stake in Tango Therapeutics, Inc., 7,182,000 shares, as a passive investor on Jun 6, 2025. Filed Jun 13, 2025 (Schedule 13G).

Stake
6.60%
Shares
7,182,000
Intent
Passive
What changed
Crossed above 5%
Filed together
28 holders

The filing in full

HolderStakeShares
Farallon Capital Partners, L.P.1.10%1,145,398
Farallon Capital Institutional Partners, L.P.1.50%1,627,113
Farallon Capital Institutional Partners II, L.P.0.30%351,630
Farallon Capital Institutional Partners III, L.P.0.20%262,855
Four Crossings Institutional Partners V, L.P.0.30%334,426
Farallon Capital Offshore Investors II, L.P.2.80%2,984,329
Farallon Capital F5 Master I, L.P.0.30%276,302
Farallon Capital (AM) Investors, L.P.0.20%199,947
Farallon Partners, L.L.C.6.40%6,905,698
Farallon Institutional (GP) V, L.L.C.0.30%334,426
Farallon F5 (GP), L.L.C.0.30%276,302
Dapice Joshua J.6.60%7,182,000
Dreyfuss, Philip D.6.60%7,182,000
Dunn Hannah E.6.60%7,182,000
Fried, Richard B6.60%7,182,000
Gehani, Varun N.6.60%7,182,000
Giauque, Nicolas6.60%7,182,000
Kim, David T.6.60%7,182,000
Linn, Michael G.6.60%7,182,000
Luo Patrick (Cheng)6.60%7,182,000
Patel, Rajiv A.6.60%7,182,000
Roberts, Jr., Thomas G.6.60%7,182,000
Saito Edric C.6.60%7,182,000
Seybold, William6.60%7,182,000
Short Daniel S.6.60%7,182,000
Spokes, Andrew J. M.6.60%7,182,000
Warren, John R.6.60%7,182,000
Wehrly, Mark C.6.60%7,182,000

Source

View original at SEC

Related